Cancer biomarkers consortium

The Cancer Biomarkers Consortium is a collaborative effort among researchers, doctors, and organizations to identify and develop biological signs—called biomarkers—that can help detect cancer early, predict how it will progress, and monitor treatment effectiveness. These biomarkers are measurable indicators, often found in blood, tissue, or other body fluids, that provide valuable information about a person's cancer. By working together, the consortium aims to improve cancer diagnosis, personalize treatments, and ultimately enhance patient outcomes through more precise and earlier detection strategies.